MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.

@article{Vegi2016MEIS2IA,
  title={MEIS2 Is an Oncogenic Partner in AML1-ETO-Positive AML.},
  author={Naidu G. M. Vegi and Josef Klappacher and Franz Oswald and Medhanie A Mulaw and Amit Mandoli and Verena N. Thiel and Shiva Bamezai and Kristin Feder and Joost H A Martens and Vijay P. S. Rawat and Tamoghna Mandal and Leticia Quintanilla-Martinez and Karsten Spiekermann and Wolfgang Hiddemann and Konstanze Doehner and Hartmut D{\"o}hner and Hendrik G. Stunnenberg and Michaela Feuring-Buske and Christian Buske},
  journal={Cell reports},
  year={2016},
  volume={16 2},
  pages={498-507}
}
Homeobox genes are known to be key factors in leukemogenesis. Although the TALE family homeodomain factor Meis1 has been linked to malignancy, a role for MEIS2 is less clear. Here, we demonstrate that MEIS2 is expressed at high levels in patients with AML1-ETO-positive acute myeloid leukemia and that growth of AML1-ETO-positive leukemia depends on MEIS2 expression. In mice, MEIS2 collaborates with AML1-ETO to induce acute myeloid leukemia. MEIS2 binds strongly to the Runt domain of AML1-ETO… CONTINUE READING
1 Citations
43 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Cutadapt removes adapter sequences from highthroughput sequencing reads

  • M. Martin
  • EMBnet J. 17, 200.
  • 2011
Highly Influential
4 Excerpts

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia

  • C.G.A.R. Network, Cancer Genome Atlas Research Network
  • N. Engl. J. Med. 368, 2059–2074.
  • 2013

Similar Papers

Loading similar papers…